Literature DB >> 12788925

Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation.

Philippe T Georgel1, Rachel A Horowitz-Scherer, Nick Adkins, Christopher L Woodcock, Paul A Wade, Jeffrey C Hansen.   

Abstract

MeCP2 is a transcriptional repressor that contains an N-terminal methylated DNA-binding domain, a central transcription regulation domain, and a C-terminal domain of unknown function. Whereas current models of MeCP2 function evoke localized recruitment of histone deacetylases to specific methylated regions of the genome, it is unclear whether MeCP2 requires DNA methylation to bind to chromatin or whether MeCP2 binding influences chromatin structure in the absence of other proteins. To address these issues, we have characterized the complexes formed between MeCP2 and biochemically defined nucleosomal arrays. At molar ratios near 1 MeCP2/nucleosome, unmethylated nucleosomal arrays formed both extensively condensed ellipsoidal particles and oligomeric suprastructures. Furthermore, MeCP2-mediated chromatin compaction occurred in the absence of monovalent or divalent cations, in distinct contrast to all other known chromatin-condensing proteins. Analysis of specific missense and nonsense MeCP2 mutants indicated that the ability to condense chromatin resides in region(s) of the protein other than the methylated DNA-binding domain. These data demonstrate that MeCP2 assembles novel secondary chromatin structures independent of DNA modification and suggest that the ability of MeCP2 to silence chromatin may be related in part to its effects on large-scale chromatin organization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788925     DOI: 10.1074/jbc.M305308200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  121 in total

1.  Site-selective in vivo targeting of cytosine-5 DNA methylation by zinc-finger proteins.

Authors:  Christopher D Carvin; Rebecca D Parr; Michael P Kladde
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

2.  Nucleosome interactions and stability in an ordered nucleosome array model system.

Authors:  Melissa J Blacketer; Sarah J Feely; Michael A Shogren-Knaak
Journal:  J Biol Chem       Date:  2010-08-25       Impact factor: 5.157

Review 3.  New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?

Authors:  Karolin Luger; Mekonnen L Dechassa; David J Tremethick
Journal:  Nat Rev Mol Cell Biol       Date:  2012-06-22       Impact factor: 94.444

Review 4.  Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.

Authors:  Jeffrey C Hansen; Rajarshi P Ghosh; Christopher L Woodcock
Journal:  IUBMB Life       Date:  2010-10       Impact factor: 3.885

Review 5.  Organization of interphase chromatin.

Authors:  Rachel A Horowitz-Scherer; Christopher L Woodcock
Journal:  Chromosoma       Date:  2005-12-17       Impact factor: 4.316

Review 6.  The end adjusts the means: heterochromatin remodelling during terminal cell differentiation.

Authors:  Sergei A Grigoryev; Yaroslava A Bulynko; Evgenya Y Popova
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

Review 7.  Chromatin architectural proteins.

Authors:  Steven J McBryant; Valerie H Adams; Jeffrey C Hansen
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

Review 8.  Recent advances in MeCP2 structure and function.

Authors:  Kristopher C Hite; Valerie H Adams; Jeffrey C Hansen
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

9.  High novelty-seeking rats are resilient to negative physiological effects of the early life stress.

Authors:  Sarah M Clinton; Stanley J Watson; Huda Akil
Journal:  Stress       Date:  2013-11-06       Impact factor: 3.493

10.  Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses.

Authors:  Tianshu Yang; Melissa B Ramocki; Jeffrey L Neul; Wen Lu; Luz Roberts; John Knight; Christopher S Ward; Huda Y Zoghbi; Farrah Kheradmand; David B Corry
Journal:  Sci Transl Med       Date:  2012-12-05       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.